Health Press Releases & Articles 351 - 355 of 771
Quark Pharmaceuticals Expands International Patent Protection For Compounds Targeting The Rtp801 Gen
26th October 2009 -
Views: 782
Quark Pharmaceuticals, Inc., a development-stage pharmaceutical company discovering and developing novel RNA interference (RNAi)-based therapeutics, today announced issuance of Japanese Patent Number: 4354633, titled, "Hypoxia regulated genes," on August 7, 2009.
Novo Nordisk Wins Design Award For Novotwist(tm) Needle
26th October 2009 -
Views: 839
Novo Nordisk has been awarded a Good Design Award(TM)(1) for NovoTwist(TM), the new needle designed for use with the insulin delivery device FlexPen(R).
Potentia Pharmaceuticals Enters Into Licensing And Purchase Option Agreements With Alcon
24th October 2009 -
Views: 801
Potentia Pharmaceuticals, a privately-held biotechnology company developing medicines for the treatment of age-related macular degeneration (AMD), announced today that it has entered into licensing and purchase option agreements with Alcon Research,
Ltd., a wholly-owned subsidiary of Alcon, Inc. (NYSE: ACL).
Reform Will Focus Health System On Patient Needs
23rd October 2009 -
Views: 872
“Part of what we’re on about is refocusing the system to keep people healthy and well, instead of just treating them when they’re sick, which is a more sustainable approach from every perspective,” Mr Snowdon said.
New Study Results Show That Patients Have Higher Treatment Satisfaction With Liraglutide Compared To
23rd October 2009 -
Views: 832
New data on patient treatment satisfaction from the LEAD(TM) 6 trial presented on the 22nd October at the 20th World Diabetes Congress (International Diabetes Federation) shows that patients have higher overall treatment satisfaction with liraglutide than they do with exenatide.
NEWS 
